Comparison |
| Container Type |
Single-Dose Vial | Prefilled Syringe |
| Generic Drug Code |
40619 | 48936 |
| NDC Number |
63361024310 | 63361024315 |
| User |
Indicated for People 6 Weeks Through 4 Years of Age | Indicated for People 6 Weeks to 4 Years of Age |
| Application |
DTaP, Polio, Hib, and Hepatitis B Vaccine | DTaP, Polio, Hib, and Hepatitis B Vaccine |
| Country of Origin |
Canada | Canada |
| Dosage Form |
Injection | Injection |
| Generic Drug Name |
Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine | Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 180 days | McKesson Acceptable Dating: we will ship >= 180 days |
| Storage Requirements |
Requires Refrigeration | Requires Refrigeration |
| Strength |
15 Lf - 5 Lf - 20 mcg - 62 DU - 53 mcg - 10 mcg / 0.5 mL | 15 Lf - 5 Lf - 20 mcg - 62 DU - 53 mcg - 10 mcg / 0.5 mL |
| Type |
Intramuscular | Intramuscular |
| UNSPSC Code |
51202101 | 51202101 |
| Volume |
0.5 mL | 0.5 mL |
| Features and Benefits |
- VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib).
- VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).
- VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit
|
|
